CMND
Price
$0.88
Change
-$0.02 (-2.22%)
Updated
Jun 26, 04:46 PM (EDT)
Capitalization
4.74M
HURA
Price
$2.30
Change
+$0.07 (+3.14%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
100.03M
Interact to see
Advertisement

CMND vs HURA

Header iconCMND vs HURA Comparison
Open Charts CMND vs HURABanner chart's image
Clearmind Medicine
Price$0.88
Change-$0.02 (-2.22%)
Volume$1.3K
Capitalization4.74M
TuHURA Biosciences
Price$2.30
Change+$0.07 (+3.14%)
Volume$3.57K
Capitalization100.03M
CMND vs HURA Comparison Chart in %
Loading...
CMND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMND vs. HURA commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMND is a StrongBuy and HURA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (CMND: $0.88 vs. HURA: $2.29)
Brand notoriety: CMND and HURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMND: 21% vs. HURA: 145%
Market capitalization -- CMND: $4.74M vs. HURA: $100.03M
CMND [@Biotechnology] is valued at $4.74M. HURA’s [@Biotechnology] market capitalization is $100.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMND’s FA Score shows that 1 FA rating(s) are green whileHURA’s FA Score has 0 green FA rating(s).

  • CMND’s FA Score: 1 green, 4 red.
  • HURA’s FA Score: 0 green, 5 red.
According to our system of comparison, CMND is a better buy in the long-term than HURA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMND’s TA Score shows that 5 TA indicator(s) are bullish while HURA’s TA Score has 4 bullish TA indicator(s).

  • CMND’s TA Score: 5 bullish, 4 bearish.
  • HURA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CMND is a better buy in the short-term than HURA.

Price Growth

CMND (@Biotechnology) experienced а +2.51% price change this week, while HURA (@Biotechnology) price change was -15.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

CMND is expected to report earnings on Jun 12, 2025.

HURA is expected to report earnings on Mar 31, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HURA($100M) has a higher market cap than CMND($4.74M). CMND YTD gains are higher at: -36.116 vs. HURA (-44.010). CMND has higher annual earnings (EBITDA): -4.91M vs. HURA (-19.52M). HURA has more cash in the bank: 6.22M vs. CMND (4.65M). CMND has less debt than HURA: CMND (36K) vs HURA (165K). CMND (0) and HURA (0) have equivalent revenues.
CMNDHURACMND / HURA
Capitalization4.74M100M5%
EBITDA-4.91M-19.52M25%
Gain YTD-36.116-44.01082%
P/E Ratio0.17N/A-
Revenue00-
Total Cash4.65M6.22M75%
Total Debt36K165K22%
FUNDAMENTALS RATINGS
HURA: Fundamental Ratings
HURA
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CMNDHURA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend about 1 month ago
85%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CMND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
THAR1.760.10
+6.03%
Tharimmune Inc.
IBRX2.790.03
+1.09%
ImmunityBio
WHG16.000.15
+0.95%
Westwood Holdings Group
DVA141.090.73
+0.52%
DaVita
SAGE9.280.03
+0.32%
Sage Therapeutics

CMND and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMND has been loosely correlated with CYTOF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CMND jumps, then CYTOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMND
1D Price
Change %
CMND100%
-2.03%
CYTOF - CMND
41%
Loosely correlated
+91.94%
SLRN - CMND
38%
Loosely correlated
N/A
CDT - CMND
32%
Poorly correlated
+2.45%
HURA - CMND
32%
Poorly correlated
+2.69%
NEUP - CMND
31%
Poorly correlated
-2.86%
More

HURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HURA has been closely correlated with BIORQ. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if HURA jumps, then BIORQ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HURA
1D Price
Change %
HURA100%
+2.69%
BIORQ - HURA
73%
Closely correlated
+4.59%
BIVI - HURA
47%
Loosely correlated
N/A
CMND - HURA
32%
Poorly correlated
-2.03%
DRUG - HURA
28%
Poorly correlated
-5.06%
CMMB - HURA
27%
Poorly correlated
-0.53%
More